Results 121 to 130 of about 1,584 (188)

Pregnancies in a patient with congenital absence of prothrombin activity: case report.

American Journal of Perinatology, 1997
Congenital hypoprothrombinemias are very rare, inherited disorders in which factor II (prothrombin) levels and/or activity are extremely low or absent. We report eight pregnancies in a patient with this disorder. Obstetric complications attributed to the
V. Catanzarite, W. Novotny, L. Cousins, J. Schneider   +3 more
semanticscholar   +2 more sources

Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.

American Journal of Clinical Pathology, 1980
Prothrombin was assayed using chromogenic substrate of S-2238 for patients who were being treated with coumarin, for patients who had liver disease, and for patients who had congenital hypoprothrombinemias and dysprothrombinemias. In coumarin therapy and
A. Girolami, G. Patrassi, Fiorenzo Toffanin, L. Saggin   +3 more
semanticscholar   +1 more source

Hemorrhagic diathesis due to factor VII deficiency.

A M A Archives of Internal Medicine, 1957
Coagulation disturbances in the second stage of clotting are basically due to deficient generation of thrombin. The prolonged one-stage prothrombin time readily places the defect in the second stage of clotting.
C. P. Barnett
semanticscholar   +1 more source

Hypoprothrombinemia Due to Cefamandole

Klinische Wochenschrift, 1988
Two patients are described with severe coagulation disturbances, in one instance leading to extensive skin bleeding, secondary to the use of cefamandole. This cefalosporin antibiotic carries the same N-methylthiotetrazole side chain as moxalactam. Pathogenetic mechanisms leading to hypoprothrombinemia, its prevention and treatment are discussed.
Leo Bossaert, H. E. Demey, Viviane M. Conraads, L. Heytens   +3 more
openaire   +2 more sources

Cefotetan-associated coagulopathies.

Archives of Surgery, 1989
To the Editor .—Two patients from our hospital (Hartford [Conn] Hospital) who developed coagulopathies supposedly from cefotetan were recently described in theArchives.
K. S. Smith, R. Quintiliani, C. Nightingale   +2 more
semanticscholar   +1 more source

Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature

Lupus, 2023
Objective Children with lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) are characterized by prolonged activated partial thromboplastin time (APTT) and prothrombin time (PT), lupus anticoagulant positivity and low prothrombin (factor II, FII ...
Yanhong Sun, Wenjian Nie, Dan‐dan Tian, Qing Ye   +3 more
semanticscholar   +1 more source